posted
Jrdig7 has a few posts on here because he post mostly on IHUB. He is very credible. He was at the RXPC shareholder meeting and has had contact with the CEO. What gets people trapped is not doing there DD and relying on other people to do it for them. He is just stating his opinion. What also gets people trapped is blindly jumping in to penny stocks and expecting to make themselves rich.
quote:Originally posted by MoneyMoneyMoney:
quote:Originally posted by jrdig7: RXPC is now listing the NOBO/OBO lists on their website again. I can't think of one other company that does this, has a friendly TA, and quotes the OS and Float on every PR.
Also, according to Peter, we will be off the pinksheets by the end of first Q of 07. Tell your friends about this one because this is one destined for dollars, imo.
DOLLARS!!??!! YOu have a few posts and are telling folks to be looking for dollars??? Your type of tongue is one that gets folks trapped looking for unrealistic gains. Try a dime to begin with and see from there...
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
Rx Processing Corp. Publishing NOBO List on a 21 Day Cycle in 2007
WILMINGTON, Del.--(Business Wire)--Rx Processing Corporation (PINK SHEETS: RXPC), re-publishes the Rx Processing Corp. NOBO list, "non-objecting shareholders list," to deter back filling actions by market makers in furtherance of affecting our goal of an additional 200 new shareholders by end of first quarter 2007.
Rx Processing Corp is reaching out in an effort to attract shareholders over the course of the next quarter to meet our target goal in 2007 of 1000 shareholders. In 2006, we realized a strong increase in the number of investors acquiring and holding shares as the company grew beyond the challenging and formative years. Through the investor awareness generated by the posting of the NOBO lists, we realize that shareholders depend on this publication to recognize actions employed by market makers.
One market maker action known as back filling is seen by the securities market as acceptable and enables them to profit while contributing to the erosion of shareholder value and confidence when investing in emerging market corporations.
Example of back filling: On December 9th 2006, Peter Fiorillo, executed the purchase of 8,550 shares of RXPC common stock over the course of 30 minutes. The bidding actions were as follows: he bid incrementally up starting at $.037 until a market maker executed his order of RXPC at the asking price of $.04. The transaction record, that proceeded within 6 seconds of execution, shows another purchase of 8500 shares at $.037 per share. This back filling action equaled a loss to the PPS of -0.003 (-7.50%) and loss of market cap of $184,900. This transaction record shows the market maker had the ability to execute the order for $.037 per share, but waited for the bid to go 7.5% higher.
"We highlight our action of posting the NOBO list and focusing on tactics used by market makers as a guide for emerging market corporations to appropriately value and restrict the dilution of their capital securities," stated, CEO of Rx Processing Corp., Peter Fiorillo.
-0- *T Total O/S: 61,633,577
Float: 21,744,502
Shareholders: 449 *T
Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
GHTI (.0033) Announces That it Anticipates 2007 Revenues to Exceed $6,000,000 Dec 11, 2006 9:15:00 AM
LAS VEGAS, NV -- (MARKET WIRE) -- 12/11/06 -- GH3 International, Inc. (PINKSHEETS: GHTI) announced today that it anticipates the 2007 revenues to exceed $6,000,000. This will be over 100% increase over the 2006 revenues.
Flo Ternes, President, CEO of GH3, states, "The year 2007 will allow us to continue in our efforts to the Company's commitment to making people feel better, look better and live longer by providing them with a proprietary, comprehensive, scientifically proven protocol for anti-aging, rejuvenation and as an effective treatment that has favorably improved chronic diseases."
In addition, the Company has retained ************ Communications to provide medial/investor relation services. This allows the Company to stay focused on the day-to-day operations and at the same time gives our shareholders quicker response time. GH3 will be utilizing the services of ************ Communications (ISC) as part of the company's ongoing efforts to bring its message to a larger audience. According to ISC President and CEO Roy Sahachaisere, "We are pleased and gratified to be working with GH3. It is our belief that GH3 is working in a niche market that has long been overlooked, but that has great appeal in both the short and long terms."
************ Communications a multimedia relations/public relations firm that specializes in bringing small and micro cap public and private companies to the attention of the general public. ************ Communications believes that there are hosts of undervalued companies that don't get the exposure they deserve, and because of their size, have been overlooked by the larger marketing companies. Many of them have solid business plans, work in potentially highly lucrative niche markets, and have superb growth potential. It is the mission of ISC to empower these companies to reap fully all of the benefits of public exposure.
Safe Harbor Statement:
Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, the amount of sales of the Company's products, the competitive environment within the industry, the ability of the Company to continue to expand its operations, the level of costs incurred in connection with the Company's expansion efforts, economic conditions in the industry and the financial strength of the Company's customers and suppliers. The Company does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
HDVY (.085) Announces Worldwide License Agreement with Pfizer
Business Wire "US Press Releases "
SAVANNAH, Ga.--(BUSINESS WIRE)--
Health Discovery Corporation ("HDC") (OTCBB: HDVY) announced today that it has executed a license agreement with Pfizer Inc. (NYSE: PFE). Under the terms of the agreement, Pfizer may access HDC's pattern recognition technology for use in its worldwide research and development activities. The license includes HDC's Support Vector Machine ("SVM"), Fractal Genomic Modeling ("FGM"), and related methods for data analysis. Financial terms of this agreement were not disclosed.
"I believe this licensing agreement represents a significant step for HDC towards validating the scientific legitimacy and commercial viability of our patented SVM and FGM technologies," said Stephen D. Barnhill, M.D., HDC's Chairman and CEO. "This license marks our third deal in just the past four months and gives us confidence that our strategic plan is on track."
"In my opinion, HDC's pattern recognition technology can be an important tool for the discovery of new drug targets such as proteins, genes, or other molecules that a drug is intended to affect," commented Dr. Herbert A. Fritsche, Jr., Professor of Laboratory Medicine at the University of Texas M.D. Anderson Cancer Center and Chairman of HDC's Science Board. "Our technology might also be helpful in possible identification of new biomarkers to assess both efficacy and toxic responses to new drugs. As medicine becomes increasingly personalized, discoveries of this nature could facilitate the development of new treatments for diseases."
Savannah-based Health Discovery Corporation (OTCBB:HDVY) is uniquely positioned in the field of pattern recognition technology. Through the application of its patent protected technology, HDC is a biology-oriented biomarker discovery company providing all aspects of First-Phase Biomarker Discovery(sm). The Company's SVM and other pattern recognition tools have significant application potential in other sizable commercial markets such as radiology, Internet search and spam, homeland security, financial futures, and other areas where analysis of large volumes of complex data is required.
This news release contains "forward-looking statements" within the meaning of Section 27a of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the management team of HDC believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.
Source: Health Discovery Corporation
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
Rx Processing Corp. Shareholder Letter December 2006 Rx Processing Corporation (Pink Sheets: RXPC), welcomes shareholders involvement in our mutual move forward towards affordable health care.
Dear Shareholders:
Our efforts have ensured RXPC and its shareholders a significant and secure future. In 2005 and 2006 considerable time was spent dealing with management of significant legal issues. RXPC brought suit against the former chief operations officer to gain back control of a 5+ million dollar asset and close the hole in the books 'reporting compliance'. This action made capital raising extremely difficult, completion of acquisitions trying and maintenance upon our focus of affordable health care, challenging, to say the least.
The alignment of company and its shareholders was further ensured by exploring a multitude of corporate positioning moves while maintaining public awareness through informative press releases. We have pursued our mission without turning RXPC into a litigiously driven company. Our intentions never changed, through our perseverance an advantageous opportunity arose and the lawsuit was ended in August, 2006.
Focus on up listing to the NASDAQ is still on the agenda today. Non-acceptance of the spin off and option agreement for DLS is but a small piece of this overall picture. In recognition, credibility gained as we pursue our vision while focusing upon RXPC's future completion of the DLS acquisition furthers our path to a future up listing. We anticipate achieving these goals in 2007. Investors value the change in direction of RXPC from focusing on corporate positioning to achieving strong valuable contracts and acquisitions that produce significant revenues for our company while meeting the projections of our published financial plan.
RXPC will sell affiliate territories, increase sales and internally capitalize the company. Shareholders, with faith and perseverance recognize that success falls on the shoulders of management and company. This investment in our beliefs and business model will continue our advocacy to service and fight for affordable, sustainable health care products and services. Through shareholder and management's cooperation we can achieve this singular goal. The continued support of our capital market breeds a positive internal message; people speak about Rx Processing Corp., its people and their mission.
The issues associated with affordable health care are by far one of the most dynamic environments on the face of the planet, and survival in this arena is truly an accomplishment. Today we recognize an ability to forgive our adversaries as our mission focus perseveres; we manifest an ability to survive through the most challenging of times.
Peter Fiorillo CEO
Rx Processing Corp.
Total O/S: 61,633,577
Float: 21,744,502
Shareholders: 449
Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
DOLLARS!!??!! YOu have a few posts and are telling folks to be looking for dollars??? Your type of tongue is one that gets folks trapped looking for unrealistic gains. Try a dime to begin with and see from there...
MoneyMoneyMoney,
Do the DD on this company. He shrunk the OS from 69 mil this Summer to 61 mil today. He has been doing some major restructuring of the company and using his own money to do it. While you may not think that is significant, I would disagree. It speaks volumes for his integrity and his belief that this company will succeed. Check out the 2 contracts that were just PR'd. This company is moving ahead and with a share structure as tight as they have, this will see dollars, imo. I have been to the shareholder's meeting, met Peter face to face, and have spent many hours via phone with him over the last 7 months.
I'll give you that most pink sheet companies never make it but feel this will be one of the few that do. We will know very soon if this company is credible or not. I'm betting that it is. GLTA
-------------------- This is not a contest. Let's all make some green. GLTA Posts: 38 | From: SC | Registered: Jun 2006
| IP: Logged |
posted
Petar also said this would be on a higher exchange by mid Nov. I did some DD and found that to be a false statement already.
There were also lots of folks at the CSHD BBQ (shareholder meetings) and spoke with Rufus but look at that example, so you attending means nothing to me.
I didn't know Petar had been doing that so therefore I didn't have the DD to say it was "insignificant" as you wrote in your words, NOT MINE. Please don't assume my thoughts.
-------------------- I buy fast and sell faster! Posts: 2018 | Registered: Jan 2006
| IP: Logged |
posted
Rx Processing Corp. Announces $1 Million Material Contract Signed with AINA Investments LLC Business Wire - January 3, 2007 9:10 AM (EDT)
WILMINGTON, Del., Jan 03, 2007 (BUSINESS WIRE) -- Rx Processing Corporation (OTC:RXPC) announces a contractual agreement with AINA Investments LLC for exclusive sales rights to license RXPC's prescription medication and laboratory diagnostic network in Florida. This action fortifies the companies' position of mutual support to the citizens of Florida through a substantive investment in Rx Processing Corp. and the state. Selling state affiliate territories in conjunction with AINA Investments LLC allows us to further our deployment of an innovative health care network. We acknowledge the increase in independent distribution channels and their contribution to our sustained profitability, diversity, separation, and mutual support.
AINA Investments gains sole and exclusive rights to license affiliate territory companies within the state of Florida. Our defined terms state a minimum license fee of $20,000, affiliates receiving a 15% commission on gross sales and a required minimum yearly sales volume of $250,000 each.
President Paul Lum, of AINA Investments LLC, stated, "This contract is a strong step forward towards providing affordable health care to all Florida residents. The lines are clear, our efforts focused; pursue responsible health care, a goal shared in common! 'AINA Investments LLC' and 'Rx Processing Corporation.'"
Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
Rx Processing Corp. Announces Material Contract Signed with Corporate Investor, Shareholder
WILMINGTON, Del.--(Business Wire)--Rx Processing Corporation (OTC:RXPC) announces a material contract with Jeff DiGenova for exclusive sales rights to license RXPC's prescription medication and laboratory diagnostic network in South Carolina. This action fortifies an ever growing network of citizens in the United States through continuing re-investment in the company. The sale of an additional state affiliate territory further reaffirms our continuing deployment of an innovative health care network.
Rx Processing Corp. has defined standards for innovation in health care for the continual commitment to U.S. Citizens with faith, focus and passion. In furtherance, shareholder Jeff DiGenova expanded a significant investment in this cause, to gain sole and exclusive rights to license affiliate territory companies within the state of South Carolina. The defined terms profess a minimum license fee of $10,000, with a material contract book value of $350,000 for the state.
Investor Jeff DiGenova said: "As an Entrepreneur and shareholder, I'm very pleased to be able to bring these much needed services to the state of South Carolina. RXPC has the ability to fill the needs of the under and uninsured here while allowing them to use the savings for what it was meant, the betterment of their lives. This is truly a win-win situation for all involved and I thank Peter for his dedication to RXPC and its mission."
"Expanding significant responsibility to groups and individuals like 'Jeff DiGenova' that share a common passion for affordable health care guarantees our efforts will bare strong returns," stated, Peter Fiorillo.
Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
Copyright Business Wire 2007 11Jan07 14:10 GMT Symbols: us;RXPC us;RXPC Source BW Business Wire
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
Our team has been working late into the evening recently. We anticipate publishing a press release (Tuesday / Wednesday) of next week.
Peter Fiorillo CEO Rx Processing Corp
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
Since inception in 2003, my money, faith, and persistence has carried everyone through these challenging formative years. I can guarantee most people invested in Rx processing corp share a common bond, the need for affordable health care or a financial gain.
Answer your questions.
1. & 2. All financial information will be delivered known when I file the Form 10 with the SEC to up list.
3. Our competition stems from storefront retail groups like CVS, Wal-mart to mail order fulfillment like Merck-Medco, Canada pharmacy, Rx-Payments ltd and others a. These groups are limited at prescription medication we have integrated Diagnostic laboratory testing to provide ease of ordering to you and your health care provider.
4. ASAP is my time frame to NASDAQ, I built Rx processing Corp from the ground up to including taking it public 'from idea to public status it took 6 months' a. I was inexperienced 3 years ago, today my experience is vast and my team is much larger and has been refined over the past years.
I look forward to you joining us for the ride.
Peter Fiorillo CEO Rx Processing Corp
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
Rx Processing Corp. Announces Return to Operations
Rx Processing Corporation (OTC:RXPC) announces a return to full operations. Our goal: a continuing advocacy to the achievement of affordable health care through innovative and integrated health care management processes for the under and uninsured. Our action to resume operations further ensures continued national market competition, thus reducing the cost and improving access to life saving prescription medications and laboratory diagnostic products.
Rx Processing Corp. understands today, more than ever, an individual's susceptibility to preventable diseases due to limited access of life saving products and services. We offer newly architected medical care fulfillment channels that appropriately fit the needs of our citizens. The pinnacle of this phased implementation throughout the following days will highlight innovative processes and management control that directly competes with major retailers and distributors.
U.S. healthcare distribution is controlled by access to clients, products, facilities, and information. Our advocacy established a core foundation and knowledge to compete in this arena. The pause in distribution in August of 2006 allowed us to realign our resources; and focus on critical elements associated with architecting a unique stand alone environment.
"Our corporate experience in service to our target clients has enlightened and changed priorities from being critical of industry and government to the recognition of a common goal, a mutual effort to achieve safe, affordable health care solutions that serve the needs of individuals having experienced the pitfalls of the current national health care architecture," stated CEO Peter Fiorillo. "Today it is with great pleasure we announce to all concerned citizens, spread the word, Rx Processing Corp. is sequentially implementing normal operations."
Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
Source: Business Wire (January 19, 2007 - 11:55 AM EST)
Rx Processing Corp. Implements Drug Interaction Software for Our Advocates
WILMINGTON, Del.--(BUSINESS WIRE)-- Rx Processing Corporation (OTC:RXPC) announces in our return to operations, we complimented the offerings to include drug interaction checking software for our advocate medical profiles. Medication interaction technology targets abnormalities common in delivering prescription medications to often knowledgeable and technology empowered citizens.
Rx Processing Corp.’s drug interaction checking empowers health care providers to accurately flag harmful combinations for its advocates. This needed over sight in ordering furthers the abilities of the dispensing pharmacist to contact the prescribing doctor to adjust patient medication regimens. This compliments drug monograph information delivered to our advocates when they complete their order.
“Providing affordable health care for the under and uninsured is more complex than simply providing distribution to a market segment,” commented CEO Peter Fiorillo. “Our implementation of drug interaction checking software will save lives and stem abuse prevalent from under and uninsured citizens vendor and doctor shopping.”
O/S: 61,633,577 Float: 21,744,502 Shareholders: 446 Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
Our team is working hard this weekend; expect a PR early in the week and possibly one by the end. I look forward to a great 2007.
Peter Fiorillo CEO Rx Processing Corp
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
Rx Processing Corp. Completes IVR Integration Operations: Phase 1 Complete Rx Processing Corporation (OTC:RXPC) completes internal development and deployment of a proprietary IVR communications system. This layered telecommunication systems architecture provides real-time scalability, flexibility and enhanced keypad order processing.
Rx Processing Corp. has designed and built a telephony communication system from the ground up to secure and further implement their point of sales system architecture. The build out included core computer programming for call automation, selection of equipment and connectivity channels and enables expansion of its service to any location in the United States within 7 days of affiliate contract acceptance. This wholly integrated architecture will be reviewed for patentable rights in 2007.
"Our operations architecture and communication system provides seamless, monitored, and clear communication channels to protect and service its advocate, non-advocate orders and their private healthcare information," commented CEO Peter Fiorillo. "Whether ordering online, over the telephone or at physical locations, our clients can rest assured, we handle all processes internally."
Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
I sold out a few weeks back. Got impatient. Always the bridesmaid. Maybe I'll get back in with some extra cash.
Posts: 942 | From: Wisconsin | Registered: Jan 2006
| IP: Logged |
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
January 26, 2007 10:05 AM US Eastern Timezone
Rx Processing Corp. Physician to Pharmacy Gateway: Phase 2 Integration
WILMINGTON, Del.--(BUSINESS WIRE)-- Rx Processing Corporation (OTC:RXPC) delivers a physician to pharmacy gateway integrated to our proprietary system. This directly connects credentialed U.S. physicians allowing access to affordable contracted pharmacies and diagnostic providers.
Rx Processing Corp. captures scripts at the point of service, direct from prescribing physicians. This innovative approach will secure advocates and clients by providing physicians a choice as to which fulfillment network they direct their patients. High priced big pharmacies issue physicians a free solution with a professed funding of 100 million dollars on their behalf. Our proprietary solution integrated with valuable laboratory diagnostics costs us a few hundred thousand dollars.
Peter Fiorillo, CEO, commented, “Physicians are on the health care front line and in concert we deliver affordable solutions to obtaining prescription medications and laboratory diagnostics."
O/S: 61,633,577 Float: 21,744,502 Shareholders: 446 Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
Looking forward to a growing, uplisting, transparent,richly rewarding experience with RXPC. Soooo much promise...a good biz plan and soooooo few shares
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
still at .085. More news should be coming very soon
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
I made 100 percent on this baby and I am out wow. I wanna stay in but I really needed to lock up a 100 percenter! I may get back in I will be watching!
-------------------- let it ride!!! Posts: 635 | From: Orlando Florida | Registered: Mar 2006
| IP: Logged |
Rx Processing Corporation (OTC:RXPC), a source of low-cost prescription medications and diagnostic laboratory tests for millions of Americans announces the board of directors declares on February 1st, 2007 an annual stock dividend to be paid on March 15th, 2007 to all shareholders.
Rx Processing Corp. shareholders will receive 3.5 shares of Rx Processing Corp. for every 100 shares held on the record date of February 21st, 2007.
Chairman Peter Fiorillo stated, "This action by the board of directors to declare a dividend in 2007 maintains RXPC's commitment to its shareholders for mutual benefit and furthers our long term relationship. "
Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
Source: Rx Processing Corporation
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
This is a big weekend for RXPC, anticipate a few press releases next week.
Peter Fiorillo CEO RX Processing Corp
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Eek!]](eek.gif)
![[Big Grin]](biggrin.gif)
